New York, NY, United States of America

Collin Chan

USPTO Granted Patents = 3 


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2014-2022

Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: Collin Chan: Innovator in Pharmaceutical Chemistry

Introduction

Collin Chan is a notable inventor based in New York, NY (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative processes for drug preparation. With a total of 3 patents to his name, Chan continues to push the boundaries of scientific research and innovation.

Latest Patents

Chan's latest patents include a process for the preparation of N-((1R,2S,5R)-5-(-butylamino)-2-((S)-3-(7--butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide. This invention generally relates to an improved method for synthesizing this complex compound. Another significant patent is for the preparation of cycloheptapyridine CGRP receptor antagonists, which includes synthetic intermediates that are useful in the overall process.

Career Highlights

Collin Chan is currently employed at Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His work focuses on developing innovative solutions that address unmet medical needs. Chan's expertise in pharmaceutical chemistry has positioned him as a valuable asset in the industry.

Collaborations

Throughout his career, Chan has collaborated with esteemed colleagues, including David Kenneth Leahy and Yu Fan. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.

Conclusion

Collin Chan exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborative efforts continue to advance the field of drug development. Chan's work not only reflects his dedication to science but also his commitment to improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…